Red Cedar Investment Management, LLC Abbott Laboratories Transaction History

Red Cedar Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $859,196 - $1.05 Million	7,437 Added 349.32%	9,566 $1.35 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $248,369 - $274,768	2,129 New	2,129 $251,000
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $475,304 - $559,980	-4,367 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $1.34 Million - $1.46 Million	-12,738 Reduced 74.47%	4,367 $478,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $1.04 Million - $1.27 Million	11,389 Added 199.25%	17,105 $1.86 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $437,674 - $560,168	5,716 New	5,716 $523,000

3,184

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Red Cedar Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Red Cedar Investment Management, LLC with notifications on news.